Hybrid Brain Computer Interface for Control of Sensory - Motor Coupling in Post - Stroke Rehabilitation (HYBIS)

December 4, 2024 updated by: Konstantinovic Ljubica, University of Belgrade

Feasibility Clinical Study of a Novel Hybrid Brain Computer Interface for Control of Sensory-motor Coupling in Post-stroke Rehabilitation

HYBIS project aims to develop an innovative and unique hybrid Brain-Computer Interface (BCI) system. This BCI system is envisioned as a novel tool for targeted reinforcement of sensory motor coupling, specifically dedicated for upper-limb post-stroke rehabilitation.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Belgrade, Serbia, 11000
        • Clinic for rehabilitation dr Miroslav Zotovic Faculty of Medicine University of Belgrade

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age over 18 years old at the time of enrolment
  • history of cerebrovascular insult verified by computerized tomography or magnetic resonance imaging;
  • stoke occurred not more than 6 months prior to study enrolment;
  • subject need to be medically and neurologically stable determined by medical history and documented neurological examination;
  • ability to understand, communicate and cooperate with the research team;
  • ability to sit for at least 45 minutes and the ability to adhere to the study rehabilitation protocol.

Exclusion Criteria:

  • any neurologic condition (beyond the stroke) or physical condition that impaired function of the affected arm
  • a substantial cardiopulmonary or metabolic disorder or other major medical complication;
  • history of seizures;
  • moderate to severe hemispatial neglect or anosognosia involving the affected arm;
  • severe sensory deficit;
  • inability to understand, cooperate, and adhere to the study procedures;
  • severe spasticity defined as Ashworth scale score of 4 in the affected arm;
  • contraindication to stimulation system placement;
  • nursing a child;
  • pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Stroke patients
Experimental group of stroke survivors for testing the feasibility of a BCI system
Testing the feasibility of BCI device by determining the accuracy of BCI control

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electrotactile BCI system accuracy
Time Frame: within 30 minutes after experimental session
Electrotactile BCI system accuracy is a measure of feasibility of the prototype device. Accuracy [0 -100 %] of classification of user's mental strategy (tactile attention task towards one of the two electrical stimulation hotspots), where higher values of accuracy are related to better system control.
within 30 minutes after experimental session
Motor Imagery BCI system accuracy
Time Frame: within 30 minutes after experimental session

Motor Imagery BCI system accuracy is a measure of feasibility of the prototype device.

Accuracy [0 - 100 %] of classification between rest and imaginary movement in a cue-based manner, , where higher values of accuracy are related to better system control.

within 30 minutes after experimental session

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl Meyer sensory score for upper extremity
Time Frame: immediately after experimental session
Fugl Meyer sensory score for upper extremity assesses the degree of sensory impairment in the upper arm. Sensation score ranges from 0 to 12 points, divided into 4 points for light touch and 12 points for position sense. Individual items pertaining to the light touch sensation of the upper arm/ forearm and palmary surface of the hand and to the position of the shoulder/ elbow/ wrist/ thumb (IP-joint) are scored on a 3-point ordinal scale and summed for a maximum possible score of 12. The higher score is considered to represent a less sensory deficit of the subject
immediately after experimental session
NASA-TLX
Time Frame: within 30 minutes after experimental session
NASA Task Load Index (NASA-TLX) method assesses workload on six scales for different aspects: mental demand, physical demand, temporal demand, performance, effort, and frustration on a 21-point scale. A higher rating represents higher workload.
within 30 minutes after experimental session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2022

Primary Completion (Estimated)

July 15, 2025

Study Completion (Estimated)

December 15, 2025

Study Registration Dates

First Submitted

November 13, 2021

First Submitted That Met QC Criteria

November 26, 2021

First Posted (Actual)

December 9, 2021

Study Record Updates

Last Update Posted (Estimated)

December 9, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on BCI feasibility test

Subscribe